Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Vet Microbiol ; 131(3-4): 277-92, 2008 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-18501535

RESUMEN

The transcriptional responses of Pasteurella multocida to eight antibiotics with known mode of actions (MoAs) and one novel antibiotic compound with an unknown MoA were collected to create a compendium of transcriptional profiles for MoA studies. At minimal inhibitory concentration the three bactericidal compounds enrofloxacin, cefquinome and the novel compound had a minor impact on gene regulation with approximately 1% of the P. multocida genome affected, whilst the bacteriostatic compounds florfenicol, tilmicosin, rifampin, trimethoprim and brodimoprim regulated 20% of the genome. Novobiocin was special in that it regulated 40% of all P. multocida genes. Regulation of target genes was observed for novobiocin, rifampin, florfenicol and tilmicosin and signature genes were identified for most antibiotics. The transcriptional profile induced by the novel compound was unrelated to the compendium profiles suggesting a new MoA. The transcription of many P. multocida virulence factors, particularly genes involved in capsule synthesis and export, LPS synthesis, competence, adherence and iron transport were altered in the presence of antibiotics. Virulence gene transcription was mainly negatively affected, however the opposite effect was also observed in the case of rifampin where the up-regulation of the tad locus involved in tight adherence was seen. Novobiocin and trimethoprim caused a marked reduction in the transcription of capsule genes, which correlated with a concomitant reduction of the capsular layer on the surface of P. multocida. The broad negative impact on virulence gene transcription supports the notion that the therapeutic effect of some antibiotics could be a combination of growth and virulence inhibition.


Asunto(s)
Antibacterianos/farmacología , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Pasteurella multocida/efectos de los fármacos , Pasteurella multocida/patogenicidad , Transcripción Genética/efectos de los fármacos , Animales , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Análisis por Conglomerados , Farmacorresistencia Bacteriana Múltiple/genética , Pasteurella multocida/genética , Pasteurella multocida/metabolismo , Virulencia
2.
Eur J Cell Biol ; 56(1): 104-12, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1666039

RESUMEN

Trypanosoma brucei bloodstream forms were incubated in a calcium-free medium containing 10 microM ethyleneglycol-bis-(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA). Under these conditions, addition of 5 microM calcium ionophore A23187 led to striking morphological alterations, as judged by light and electron microscopy. The cytoskeleton of trypanosomes consists of a subpellicular corset of microtubules. Characteristically four of these microtubules are attached invariantly to an extension of the endoplasmic reticulum at the flagellar attachment site. Specifically in this area calcium depletion led to the polymerization of additional microtubules and to a retraction of the endoplasmic reticulum extension from its usual position. Additionally, A23187 led to nucleolus segregation, as revealed by immunocytochemistry using antibodies against DNA and fibrillarin, respectively. Nucleolus segregation, but not microtubule accumulation, was also obtained by using 20 microM camptothecin, a specific inhibitor of topoisomerase I. Our data suggest that intracellular calcium regulation might be important for specific depolymerization/polymerization reactions during the course of cell division and the formation of functional ribosomes.


Asunto(s)
Calcio/metabolismo , Nucléolo Celular/metabolismo , Citoesqueleto/metabolismo , Trypanosoma brucei brucei/metabolismo , Animales , Calcimicina/farmacología , Camptotecina/farmacología , Nucléolo Celular/efectos de los fármacos , Nucléolo Celular/ultraestructura , Proteínas Cromosómicas no Histona/inmunología , Proteínas Cromosómicas no Histona/aislamiento & purificación , Citoesqueleto/efectos de los fármacos , Citoesqueleto/ultraestructura , ADN/inmunología , ADN/aislamiento & purificación , Ácido Egtácico/farmacología , Secciones por Congelación , Microscopía Electrónica , Proteínas/metabolismo , Piruvatos/metabolismo , Inhibidores de Topoisomerasa I , Trypanosoma brucei brucei/efectos de los fármacos , Trypanosoma brucei brucei/inmunología , Trypanosoma brucei brucei/ultraestructura
3.
Eur J Cell Biol ; 69(2): 173-9, 1996 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8907618

RESUMEN

Long slender trypanosomes, isolated from infected mouse blood or from cryopreserved stabilates, respectively, were unable to grow in conditioned media (cMEM), prepared from the declining phase of axenic bloodstream form cultures. Additionally, mixtures of fresh medium and cMEM led to decreased growth rates and, in accordance to the amount of cMEM used, to a decreased S-adenosyl-L-methionine decarboxylase (Ado-MetDC; E.C. 4.1.1.50) activity. Since addition of polyamines could not overcome the process of transition from dividing to non-dividing cells and the intracellular S-adenosyl-L-methionine (AdoMet), ornithine and putrescine concentrations seemed unaltered during the course of cultivation, we questioned if polyamine metabolism is involved in this transition process. Activities of two key enzymes of polyamine metabolism, AdoMetDC and ornithine decarboxylase (ODC; E.C. 4.1.1.17) were therefore monitored during different growth stages. Our results revealed a specific activity of 44 pmol min-1 mg protein-1 for AdoMetDC and a KM of 10 mu M for AdoMet. Methylglyoxal bis(guanylhydrazone) showed a Ki of 6 mu M. The constant activity of the enzyme during a 7 h time-course in the presence of cycloheximide indicates a t1/2 of more than 7 h for the trypanosomal enzyme. Enzyme activity in trypanosomes isolated from infected laboratory animals and from logarithmic phase bloodstream or procyclic form cultures was high according to a high dividing rate, whereas enzyme activity in parasites isolated from the stationary phase of bloodstream from culture was negligible. In these cultures, AdoMetDC activity decreased with a t1/2 of 7 h during transition from long slender to short stumpy-like forms as soon as the stationary phase was reached. ODC activity was high (approximately 300 pmol min-1 mg protein-1) in dividing trypanosomes isolated from infected animals as well as from logarithmic phase bloodstream or procyclic form cultures and decreased also during transition with a t1/2 of 10 h.


Asunto(s)
Adenosilmetionina Descarboxilasa/genética , Vida Libre de Gérmenes , Biosíntesis de Proteínas , Trypanosoma brucei brucei/genética , Animales , Diferenciación Celular/fisiología , Técnicas de Cultivo , Regulación hacia Abajo , Modelos Logísticos , Ornitina Descarboxilasa/metabolismo , Trypanosoma brucei brucei/enzimología
4.
Mol Biochem Parasitol ; 92(2): 275-89, 1998 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-9657332

RESUMEN

Cysteine proteases play vital biological roles in both intracellular and extracellular environments. A cysteine protease migrating at 30 kDa was identified in somatic extracts of Toxocara canis larvae (TEX), by its binding to the biotinylated inhibitor Phe-Ala-CH2F. TEX proteases readily cleaved the cathepsin L- and B-specific peptide substrate Z-Phe-Arg-AMC and to a lesser extent, the cathepsin B-specific peptide Z-Arg-Arg-AMC. Excretory/secretory (TES) products of T. canis larvae did not cleave either substrate. Partial sequence encoding the 5' end of a cysteine protease cDNA from infective T. canis larvae was then obtained from an expressed sequence tag (EST) project. The entire cDNA (termed Tc-cpl-1) was subsequently sequenced and found to encode a preproenzyme similar to cathepsin L-like proteases (identities between 36 and 69%), the closest homologues being two predicted proteins from Caenorhabditis elegans cosmids, a cathepsin L-like enzyme from Brugia pahangi and a range of parasite and plant papain-like proteases. Sequence alignment with homologues of known secondary structure indicated several charged residues in the S1 and S2 subsites involved in determining substrate specificity. Some of these are shared with human cathepsin B, including Glu 205 (papain numbering), known to permit cleavage of Arg-Arg peptide bonds. The recombinant protease (rTc-CPL-1) was expressed in bacteria for immunisation of mice and the subsequent antiserum shown to specifically react with the 30 kDa native protease in TEX. Sera from mice infected with the parasite also contained antibodies to rTc-CPL-1 as did sera from nine patients with proven toxocariasis; control sera did not. Larger scale studies are underway to investigate the efficacy of rTc-CPL-1 as a diagnostic antigen for human toxocariasis, the current test for which relies on whole excretory/secretory antigens of cultured parasites.


Asunto(s)
Cisteína Endopeptidasas/genética , Cisteína Endopeptidasas/aislamiento & purificación , Endopeptidasas , Toxocara canis/enzimología , Secuencia de Aminoácidos , Animales , Anticuerpos Antihelmínticos/análisis , Secuencia de Bases , Catepsina L , Catepsinas/química , Clonación Molecular , Cisteína Endopeptidasas/inmunología , Cisteína Endopeptidasas/metabolismo , ADN Protozoario , Femenino , Regulación de la Expresión Génica , Humanos , Larva/enzimología , Larva/genética , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Filogenia , Homología de Secuencia de Aminoácido , Toxocara canis/clasificación , Toxocara canis/genética , Toxocariasis/inmunología , Toxocariasis/parasitología
5.
Mol Biochem Parasitol ; 70(1-2): 157-66, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7637696

RESUMEN

We used an axenic cultivation system to grow African trypanosomes in vitro. Long-term cultivation for more than 60 days has been achieved by replacing the culture medium at regular intervals between 6 and 48 h. In contrast to a control culture without medium replacement, increasing amounts of maximum cell concentrations have been obtained, ranging from 5 x 10(6) to 2 x 10(7) trypanosomes ml-1, whereas the generation doubling time remained constant (about 6 h). Higher cell concentrations have only been obtained by total medium replacement; neither addition of fresh medium nor serum led to a higher cell yield, suggesting that a trypanosome-derived factor or metabolite accumulated in the medium rather than medium was depleted of an essential nutrient. Most interestingly, however, successive waves have been obtained which eventually led to a damped oscillation curve with a constant high population density after about 40 days of cultivation. Cultures were started with a homogeneous population of the long-slender form. As judged by light microscopy, cells showed a stumpy morphology during the declining phase and became slender again in the following growth phase. At later time points, when cells remained in a stationary phase at high population density, many different morphological stages have been observed, similar to those described by early authors as intermediate forms [Ormerod, W. E. (1979) In: Biology of the Kinetoplastida, Vol. 2, pp. 340-393], although many dividing forms are still present at that time. In contrast, identically treated procyclic cultures were unable to produce cyclic growth waves. Based on these results, a novel concept considering a possible differentiation mechanism is discussed.


Asunto(s)
Parasitología/métodos , Trypanosoma brucei brucei/crecimiento & desarrollo , Animales , Fenómenos Fisiológicos Sanguíneos , Medios de Cultivo Condicionados/química , Inhibidores de Crecimiento/aislamiento & purificación , Ratones , Ratones Endogámicos , Peso Molecular , Parasitemia/parasitología , Ratas , Ratas Sprague-Dawley , Trypanosoma brucei brucei/ultraestructura , Tripanosomiasis Africana/sangre , Tripanosomiasis Africana/parasitología
6.
Invest Radiol ; 20(8): 860-6, 1985 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2934348

RESUMEN

The intrinsic optical properties of normal and diseased vascular tissues and their interaction with continuous wave (cw) and pulsed laser light were investigated to determine the optimal source for laser angioplasty. Both intima and atheromatous plaque demonstrated increasing spectral absorbance at shorter wavelengths (in the near ultraviolet). The relative differences in absorbance between diseased and nondiseased tissues were not sufficient to allow selective ablation of plaque. Atheromatous plaque appears more resistant than normal intima to damage by cw argon laser. The interaction of tissue with a high-power, pulsed ultraviolet laser showed a nonlinear response as pulse repetition rate and pulse energy were varied. From theoretical considerations and our experimental results, we propose that a pulsed ultraviolet laser with 50 millijoules of power per pulse and a repetition rate of 10 pps would be safer and more effective for recanalization than the cw argon laser.


Asunto(s)
Angioplastia de Balón/métodos , Arteriosclerosis/terapia , Terapia por Láser , Angioplastia de Balón/instrumentación , Humanos , Técnicas In Vitro
7.
Acad Radiol ; 4(7): 475-82, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9232166

RESUMEN

RATIONALE AND OBJECTIVES: The authors assessed health-related quality of life changes associated with peripheral x-ray angiography and magnetic resonance (MR) angiography. MATERIALS AND METHODS: Utility (the desirability or preference that individuals exhibit for a particular health state) was assessed in 30 patients with peripheral vascular disease referred for angiography by using a rating scale, additional categoric scaling questions to separate preference from experience, a willingness-to-pay technique, functional and cognitive status questions, and a time trade-off technique. All patients underwent both MR angiography and x-ray angiography. RESULTS: Patients reported significantly (P < .05) less anxiety after the test, less pain after the test, fewer new physical limitations, and less effect on performance of daily activities with MR angiography. Findings from the overall rating scale and categoric scaling questions also significantly (P < .05) favored MR angiography. Patients were willing to pay a mean of 2.12% of annual income to avoid MR angiography and a mean of 7.41% to avoid x-ray angiography. The median quality-adjusted life gain required by patients to undergo the procedures was 52.5-60 days for x-ray angiography and 10.5 days for MR angiography, without discounting. CONCLUSION: X-ray angiography has more profound short-term adverse effects on life than does MR angiography. Preference-based measures can be adapted to elicit patient values for short-term health states as seen in radiology.


Asunto(s)
Angiografía/psicología , Angiografía por Resonancia Magnética/psicología , Enfermedades Vasculares Periféricas/diagnóstico , Calidad de Vida , Angiografía/economía , Actitud Frente a la Salud , Análisis Costo-Beneficio , Femenino , Financiación Personal , Humanos , Angiografía por Resonancia Magnética/economía , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Enfermedades Vasculares Periféricas/psicología , Factores de Tiempo
9.
Genomics ; 89(1): 36-43, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17070005

RESUMEN

A modern concept for the development of novel antiparasitic drugs is the combination of bioinformatics and chemoinformatics approaches. This covers, for example, the identification of target proteins serving as molecular points of attack for parasiticides--the idea is that, owing to some essential role, inhibition of a target protein should eradicate the parasite. To prevent toxicity problems for vertebrate host organisms, it is advantageous that these proteins show significant differences from their vertebrate counterparts. In the present work, we identified potential target proteins in parasitic nematodes (Ascaris suum, Brugia malayi, and Haemonchus contortus) and arthropods (Boophilus microplus and Rhipicephalus appendiculatus) using bioinformatic sequence comparison methods on expressed sequence tags. Interesting target proteins (e.g., S-adenosyl-l-methionine synthetase) were characterized in detail by subjecting them to in-depth bioinformatic analysis. S-Adenosyl-l-methionine synthetase was also used to elucidate chemoinformatics approaches like homology modeling and docking, which represent appropriate methods for generating valuable data for the development of new drug candidates.


Asunto(s)
Antiparasitarios/química , Biología Computacional , Diseño de Fármacos , Secuencia de Aminoácidos , Animales , Artrópodos/efectos de los fármacos , Artrópodos/genética , Drosophila melanogaster/enzimología , Drosophila melanogaster/genética , Etiquetas de Secuencia Expresada , Proteínas del Helminto/efectos de los fármacos , Proteínas del Helminto/genética , Metionina Adenosiltransferasa/antagonistas & inhibidores , Metionina Adenosiltransferasa/genética , Modelos Moleculares , Datos de Secuencia Molecular , Nematodos/efectos de los fármacos , Nematodos/genética , Homología de Secuencia de Aminoácido
10.
Opt Lett ; 1(3): 90-2, 1977 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-19680340

RESUMEN

The first direct observation of radiative spectral transfer within an inhomogeneously broadened line (the R(1) line of ruby) is reported. As opposed to nonradiative transfer, the temperature dependence of the radiative process is consistent with exponential, in agreement with recent predictions. A temperature-independent, resonant process is also directly observed. The implication of these results for the concept of microscopic strain broadening is discussed.

11.
Appl Opt ; 15(5): 1158-63, 1976 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-20165144

RESUMEN

A tunable jet-stream dye laser pumped by a cavity-dumped argon laser has been synchronized to a photoelastic modulator to measure magnetic circular dichroism. Gated signal amplification takes advantage of the laser's pulsed operation to detect weak dichroic signals. Comparative data show that the dye laser and gated amplification give a SNR better than that obtained with the previously used lamp, monochromator, and lockin detector. Other applications of the dye laser and gated amplification are discussed.

12.
Biochem J ; 340 ( Pt 1): 113-7, 1999 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-10229665

RESUMEN

The mature form of the cathepsin B-like protease of Leishmania major (LmajcatB) is a 243 amino acid protein belonging to the papain family of cysteine proteases and is 54% identical to human-liver cathepsin B. Despite the high identity and structural similarity with cathepsin B, LmajcatB does not readily hydrolyse benzyloxycarbonyl-Arg-Arg-7-amino-4-methyl coumarin (Z-Arg-Arg-AMC), which is cleaved by cathepsin B enzymes. It does, however, hydrolyse Z-Phe-Arg-AMC, a substrate typically cleaved by cathepsin L and B enzymes. Based upon computer generated protein models of LmajcatB and mammalian cathepsin B, it was predicted that this variation in substrate specificity was attributed to Gly234 at the S2 subsite of LmajcatB, which forms a larger, more hydrophobic pocket compared with mammalian cathepsin B. To test this hypothesis, recombinant LmajcatB was expressed in the Pichia pastoris yeast expression system. The quality of the recombinant enzyme was confirmed by kinetic characterization, N-terminal sequencing, and Western blot analysis. Alteration of Gly234 to Glu, which is found at the corresponding site in mammalian cathepsin B, increased recombinant LmajcatB (rLmajcatB) activity toward Z-Arg-Arg-AMC 8-fold over the wild-type recombinant enzyme (kcat/Km=3740+/-413 M-1.s-1 versus 472+/-72.4 M-1.s-1). The results of inhibition assays of rLmajcatB with an inhibitor of cathepsin L enzymes, K11002 (morpholine urea-Phe-homoPhe-vinylsulphonylphenyl, kinact/Ki=208200+/-36000 M-1. s-1), and a cathepsin B specific inhibitor, CA074 [N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-l-isoleucyl-l- prolin e, kinact/Ki=199200+/-32900 M-1.s-1], support the findings that this protozoan protease has the P2 specificity of cathepsin L-like enzymes while retaining structural homology to mammalian cathepsin B.


Asunto(s)
Catepsina B/genética , Catepsina B/metabolismo , Leishmania major/enzimología , Mutagénesis Sitio-Dirigida , Mutación , Secuencia de Aminoácidos , Animales , Sitios de Unión , Catepsina B/antagonistas & inhibidores , Catepsina B/química , Cumarinas/metabolismo , Dipéptidos/farmacología , Ácido Glutámico/genética , Ácido Glutámico/metabolismo , Glicina/genética , Glicina/metabolismo , Humanos , Concentración de Iones de Hidrógeno , Cinética , Leishmania major/genética , Datos de Secuencia Molecular , Pichia/genética , Ratas , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido , Relación Estructura-Actividad , Especificidad por Sustrato , Sulfonas/farmacología
13.
Int J Med Microbiol ; 290(2): 191-201, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-11045924

RESUMEN

In the 20th century and especially during the last 50 years, antiinfectives have been increasingly used to control and prevent infectious diseases. Unfortunately the resistance of microorganisms to these pharmaceuticals has increased as well. At the same time the discovery process for novel antiinfectives, the so-called "conventional" screening approach, involves testing natural products or derivatives of known compounds in in vitro cultures. By now it is obvious that this screening approach did not meet the expectations to generate a sufficient number of novel drug candidates. Consequently, studies for selective antiinfectives with new modes of action, which are able to break resistance, are highly desirable for human and animal health. The enormous advance in sequencing technologies--leading to a constantly growing number of known microbial genomes--together with the rapid development of computer power and bioinformatic software tools, now makes it possible to identify genes and gene products that are essential to the pathogenic organisms and are therefore considered to be novel targets for the development of new antiinfectives. When these potential targets have been validated by sophisticated laboratory methods, large diverse compound libraries can be tested in in vitro assays using high-throughput screening. This approach will most likely generate an increasing number of novel lead structures that will be specifically optimized by modern combinatorial chemistry and subsequently lead to new antiinfective candidates strengthening the armoury of weapons available to fight infectious diseases in humans and animals.


Asunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Proteínas Bacterianas/efectos de los fármacos , Proteínas Bacterianas/genética , Diseño de Fármacos , Animales , Bacterias/genética , Bacterias/metabolismo , Infecciones Bacterianas/microbiología , Proteínas Bacterianas/metabolismo , Biología Computacional , Genómica/métodos , Humanos
14.
J Vasc Surg ; 22(2): 173-7, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7637118

RESUMEN

We report a series of four acute external iliac artery dissections occurring in three patients within days of completion of ultraendurance athletic events. Acute dissection of the external iliac artery in highly trained athletes after competition has not been previously documented. A retrospective review of three cases was performed with subsequent follow-up, including imaging and hemodynamic measurements. Dissection was suspected on the basis of duplex imaging results in one case, and arteriography confirmed dissection in all cases. All patients were endurance athletes over the age of 40 years. One patient was found to have bilateral lesions. Treatment in two cases was initiated with percutaneous transluminal angioplasty, one with a successful result and subsequent Plamaz stent placement. In the other case percutaneous transluminal angioplasty was unsuccessful, and operative repair was required with the placement of a graft. The final patient who had bilateral involvement was treated conservatively. At a mean follow-up of 32 months, there have been no complications, and all patients have normal resting hemodynamics. Follow-up duplex imaging shows healing of the dissections in the untreated patient. Histopathologic study in the patient treated with operation disclosed dissection in an otherwise normal arterial wall. Highly trained athletes over the age of 40 are susceptible to external iliac artery dissection, and successful treatment has been achieved by surgical, endovascular, and conservative therapies.


Asunto(s)
Disección Aórtica/diagnóstico , Ciclismo , Arteria Ilíaca , Carrera , Natación , Enfermedad Aguda , Disección Aórtica/etiología , Disección Aórtica/terapia , Angioplastia , Angioplastia de Balón , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Arteria Ilíaca/diagnóstico por imagen , Arteria Ilíaca/cirugía , Masculino , Persona de Mediana Edad , Radiografía , Estudios Retrospectivos , Stents , Ultrasonografía
15.
Am Heart J ; 112(4): 739-45, 1986 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3766373

RESUMEN

The effects of XeF1 excimer laser on isolated normal and atherosclerotic aorta were studied. Experiments were performed in flowing water at constant temperature, flow rate, water depth, pulse width (10 nsec), wavelength (351 nm), beam size (1 mm2) and focal length (50 cm). The number of pulses, the pulse energy, and the pulse frequency were varied, and the vascular tissue was studied histologically. The following observations were made: tissue ablation required a minimum threshold pulse energy and was nonlinearly proportional to the number of pulses and the pulse energy delivered; precise tissue ablation occurred at low pulse frequencies, but changes resembling a thermal process were seen as pulse frequency increased; calcified plaque was more photoresistant than atheroma or normal vessel; excimer laser energy was markedly attenuated by blood; and the time interval between pulses and high peak power are related to the precision of ablation by pulsed excimer laser. It is concluded that excimer laser can rapidly and precisely ablate vascular tissue by a photothermal process.


Asunto(s)
Rayos Láser , Músculo Liso Vascular , Aorta , Arteriosclerosis/radioterapia , Humanos , Factores de Tiempo
16.
Bioorg Med Chem ; 6(12): 2477-94, 1998 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9925304

RESUMEN

The inhibition of cysteine proteases is being studied as a strategy to combat parasitic diseases such as Chagas' disease, leishmaniasis, and malaria. Cruzain is the major cysteine protease of Trypanosoma cruzi, the etiologic agent of Chagas' disease. A crystal structure of cruzain, covalently inactivated by fluoromethyl ketone inhibitor 1 (Cbz-Phe-Ala-FMK), was used as a template to design potential inhibitors. Conformationally constrained gamma-lactams containing electrophilic aldehyde (12, 17, 18, 25, 26, and 29) or vinyl sulfone (43, 44, and 46) units were synthesized. Constrained lactam 26 had IC50 values of ca. 20 nM against the Leishmania major protease and ca. 50 nM versus falcipain, an important cysteine protease isolated from Plasmodium falciparum. However, all of the conformationally constrained inhibitors were weak inhibitors of cruzain, compared to unconstrained peptide aldehyde (e.g. 5 ) and vinyl sulfone inhibitors (e.g. 48, which proved to be an excellent inhibitor of cruzain with an apparent second order inhibition rate constant (k(inact)/Ki) of 634,000s(-1)M(-1). A significant reduction in activity was also observed with acyclic inhibitors 30 and 51 containing alpha-methyl phenylalanine residues at the P2 position. These data indicate that the pyrrolidinone ring, especially the quarternary center at P2, interferes with the normal substrate binding mode with cruzain, but not with falcipain or the leishmania protease.


Asunto(s)
Cisteína Endopeptidasas/metabolismo , Inhibidores de Cisteína Proteinasa/síntesis química , Lactamas/síntesis química , Proteínas Protozoarias/metabolismo , Pirrolidinas/síntesis química , Tripanocidas/síntesis química , Animales , Cristalografía por Rayos X , Cisteína Endopeptidasas/química , Inhibidores de Cisteína Proteinasa/química , Inhibidores de Cisteína Proteinasa/farmacología , Diseño de Fármacos , Cinética , Lactamas/química , Lactamas/farmacología , Conformación Molecular , Estructura Molecular , Plasmodium falciparum/enzimología , Proteínas Protozoarias/química , Pirrolidinas/química , Pirrolidinas/farmacología , Relación Estructura-Actividad , Sulfonamidas/síntesis química , Sulfonamidas/química , Sulfonamidas/farmacología , Tripanocidas/química , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/enzimología
17.
Radiology ; 171(1): 135-40, 1989 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2928517

RESUMEN

Six painful hips in five patients were examined with magnetic resonance (MR) imaging and were found to have diffuse signal abnormalities in the marrow of the femoral head and neck, which extended into the intertrochanteric area in five cases. The abnormal regions were low in signal intensity on images obtained with a short repetition time (TR) and a short echo time (TE) and were isointense or hyperintense on long TR/TE images--findings that have been attributed by others to bone marrow edema. Edema was also seen in marrow just above the acetabulum in two cases. No focal abnormalities characteristic of osteonecrosis were seen. Osteonecrosis was subsequently shown to be present in all six femoral heads at core biopsy (three cases) or by subsequent development of focal MR abnormalities reported to be highly specific for osteonecrosis (three cases). The affected hips had been radiographically normal or subtly osteopenic and had shown intense radionuclide uptake in the femoral head at scintigraphy, with lesser abnormality in the neck and intertrochanteric region. Follow-up MR examinations of five of the six femoral heads showed the diffuse abnormalities to have been transient. Although diffuse MR abnormalities in the proximal femur are not specific, they may indicate the presence of osteonecrosis of the femoral head.


Asunto(s)
Médula Ósea/patología , Necrosis de la Cabeza Femoral/diagnóstico , Imagen por Resonancia Magnética , Adulto , Anciano , Biopsia , Femenino , Cabeza Femoral/patología , Necrosis de la Cabeza Femoral/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Cintigrafía
18.
Exp Parasitol ; 87(3): 212-21, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9371086

RESUMEN

The crystal structures of papain, cruzain, and human liver cathepsin B were used to build homology-based enzyme models of a cathepsin L-like cysteine protease (cpL) and a cathepsin B-like cysteine protease (cpB) from the protozoan parasite Leishmania major. Although structurally a member of the cathepsin B subfamily, the L. major cpB is not able to cleave synthetic substrates having an arginine in position P2. This biochemical property correlates with the prediction of a glycine instead of a glutamic acid at position 205 (papain numbering). The modeled active sites of the L. major cpB and cpL were used to screen the Available Chemicals Directory (a database of about 150,000 commercially available compounds) for potential cysteine protease inhibitors, using DOCK3.5. Based on both steric and force field considerations, 69 compounds were selected. Of these, 18 showed IC50's between 50 and 100 microM and 3 had IC50's below 50 microM. A secondary library of compounds, originally derived from a structural screen against the homologous protease of Plasmodium falciparum (falcipain), and subsequently expanded by combinatorial chemistry, was also screened. Three inhibitors were identified which were not only effective against the L. major protease but also inhibited parasite growth at 5-50 microM.


Asunto(s)
Cisteína Endopeptidasas/química , Inhibidores de Cisteína Proteinasa/farmacología , Endopeptidasas , Leishmania major/enzimología , Tripanocidas/farmacología , Animales , Compuestos Azo/farmacología , Sitios de Unión , Catepsina B/efectos de los fármacos , Catepsina L , Catepsinas/efectos de los fármacos , Simulación por Computador , Cisteína Endopeptidasas/efectos de los fármacos , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Ácido Fólico/análogos & derivados , Ácido Fólico/farmacología , Hidrazinas/farmacología , Modelos Moleculares , Alineación de Secuencia , Succinimidas/farmacología , Ésteres del Ácido Sulfúrico/farmacología , Tripanocidas/química
19.
Proc Natl Acad Sci U S A ; 96(20): 11015-22, 1999 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-10500116

RESUMEN

Papain family cysteine proteases are key factors in the pathogenesis of cancer invasion, arthritis, osteoporosis, and microbial infections. Targeting this enzyme family is therefore one strategy in the development of new chemotherapy for a number of diseases. Little is known, however, about the efficacy, selectivity, and safety of cysteine protease inhibitors in cell culture or in vivo. We now report that specific cysteine protease inhibitors kill Leishmania parasites in vitro, at concentrations that do not overtly affect mammalian host cells. Inhibition of Leishmania cysteine protease activity was accompanied by defects in the parasite's lysosome/endosome compartment resembling those seen in lysosomal storage diseases. Colocalization of anti-protease antibodies with biotinylated surface proteins and accumulation of undigested debris and protease in the flagellar pocket of treated parasites were consistent with a pathway of protease trafficking from flagellar pocket to the lysosome/endosome compartment. The inhibitors were sufficiently absorbed and stable in vivo to ameliorate the pathology associated with a mouse model of Leishmania infection.


Asunto(s)
Antiprotozoarios/farmacología , Inhibidores de Cisteína Proteinasa/farmacología , Leishmania major/efectos de los fármacos , Animales , Células Cultivadas , Inhibidores de Cisteína Proteinasa/uso terapéutico , Inhibidores de Cisteína Proteinasa/toxicidad , Femenino , Leishmania major/ultraestructura , Leishmaniasis Cutánea/tratamiento farmacológico , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica
20.
Bioorg Med Chem ; 4(9): 1421-7, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8894100

RESUMEN

To streamline the preclinical phase of pharmaceutical development, we have explored the utility of structural data on the molecular target and synergy between computational and medicinal chemistry. We have concentrated on parasitic infectious diseases with a particular emphasis on the development of specific noncovalent inhibitors of proteases that play a key role in the parasites' life cycles. Frequently, the structure of the enzyme target of pharmaceutical interest is not available. In this setting we have modeled the structure of the relevant enzyme by virtue of its sequence similarity with proteins of known structure. For example, we have constructed a homology-based model of falcipain, the trophozoite cysteine protease, and used the computational ligand identification algorithm DOCK to identify in compuo enzyme inhibitors including oxalic bis(2-hydroxy-1-naphthyl-methylene)hydrazide (1) [Ring, C. S.; Sun, E.; McKerow, J. H.; Lee, G.; Rosenthal, P. J., Kuntz, I. D.; Cohen, F. E., Proc. Natl Acad. Sci. U.S.A. 1993, 90, 3583]. Compound 1 inhibits falcipain (IC50 6 microM) and the organism in vitro as judged by hypoxanthine uptake (IC50 7 microM). Following this lead, to date, we have identified potent bis arylacylhydrazides (IC50 150 nM) and chalcones (IC50 200 nM) that are active against both chloroquine-sensitive and chloroquine-resistant strains of malaria. In a second example, cruzain, the crystallographically determined structure of a papain-like cysteine protease, resolved to 2.35 A, was available. Aided by DOCK, we have identified a family of bis-arylacylhydrazides that are potent inhibitors of cruzain (IC50 600 microM). These compounds represent useful leads for pharmaceutical development over strict enzyme inhibition criteria in a structure-based design program.


Asunto(s)
Diseño de Fármacos , Parásitos/enzimología , Inhibidores de Proteasas/química , Aldehídos , Animales , Cristalografía por Rayos X , Hidrazinas , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Plasmodium falciparum/enzimología , Conformación Proteica , Relación Estructura-Actividad , Trypanosoma cruzi/enzimología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda